Table 3.
Risk of vaccine-preventable disease in preterm and LBW infants
Disease | Outcome | Risk of acquiring disease |
---|---|---|
Diphtheria |
|
n.r.¥ |
Tetanus |
|
OR: 2.09 (95%CI: 1.29–3.37)63 |
Pertussis |
|
IRR: 1.99 (95%CI: 1.47–2.71)64 |
|
OR: 5.00 (95%CI: 1.27–19.71)65 | |
Polio |
|
n.r. ¥ |
Hepatitis B |
|
n.r. ¥ |
Invasive pneumococcal disease |
|
RR: 2.6 (P = .03)39 |
|
RR: 1.6 (P = .06)39 | |
Bacterial meningitis |
|
RR: 1.38 (95%CI: 0.57–3.35)66 RR: 1.46 (95%CI: 0.88–2.44)66 RR: 1.55 (95%CI: 1.13–2.12)66 RR: 1.31 (95%CI: 1.09–1.58)66 |
Bacterial pneumonia |
|
RR: 2.86 (95%CI: 1.83–4.47)66 RR: 1.67 (95%CI: 1.20–2.33)66 RR: 1.53 (95%CI: 1.22–1.91)66 RR: 1.51 (95%CI: 1.32–1.71)66 |
Rotavirus gastroenteritis |
|
OR: 2.6 (95%CI: 1.6–4.1)67 |
|
OR: 1.6 (95%CI: 1.3–2.1)67 | |
Influenza |
|
OR: 2.53 (95%CI: 1.34–4.77)68 |
ƘAge data reflect a higher proportion of cases in the adolescent and adult populations. These populations could be the source of infection in preterm and LBW infants
¥No data was found for these diseases. It can be assumed that there is a high risk of these diseases occurring given the immaturity of the immune system of the preterm and LBW infant
CI: confidence interval; IRR: incidence rate ratio; LBW: low birth weight; OR: odds ratio; P: p-value; RR: relative risk